Mirion Technologies, Inc. (MIR)
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
Sector: Measuring & Controlling Devices, NEC
Industry: Industrial - Machinery
Mirion Technologies, Inc.
No splits on record
Nothing in MIR's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $925.4M | $860.8M | $800.9M | $717.8M | $668.3M | $0 | $440.1M | $444.1M |
| YoY Growth | 7.5% | 7.5% | 11.6% | 7.4% | - | - | -0.9% | - |
| Cost of Revenue | $486.8M | $459M | $444.4M | $400.6M | $384.1M | $0 | $251.8M | $275.7M |
| Gross Profit | $438.6M | $401.8M | $356.5M | $317.2M | $284.2M | $0 | $188.3M | $168.4M |
| Gross Margin | 47.4% | 46.7% | 44.5% | 44.2% | 42.5% | - | 42.8% | 37.9% |
| Research and Development | $38.9M | $35M | $31.7M | $30.3M | $36.2M | $0 | $14M | $19.3M |
| Selling, General, and Administrative | $348.2M | $338.2M | $338.6M | $357.1M | $267.6M | $2.45M | $145.4M | $153.8M |
| Other | $0 | $3.8M | $8.1M | $227.6M | $49.1M | $0 | $100K | $0 |
| Total Operating Expenses | $387.1M | $377M | $378.4M | $615M | $352.9M | $2.45M | $159.5M | $173.1M |
| Operating Income (EBIT) | $51.5M | $24.8M | -$21.9M | -$297.8M | -$68.7M | -$2.45M | $28.8M | -$4.7M |
| Operating Margin | 5.6% | 2.9% | -2.7% | -41.5% | -10.3% | - | 6.5% | -1.1% |
| Interest Expense | $42.2M | $57.9M | $61.9M | $42.5M | $59M | $0 | $0 | $0 |
| Interest Income | $12.1M | $6.6M | $4.8M | $600K | $145.8M | $0 | $0 | $0 |
| Other Income (Expense) | -$18.8M | -$58.7M | -$83.4M | -$8.8M | -$159.8M | -$43.07M | -$155M | -$135.8M |
| Income Before Tax (EBT) | $32.7M | -$33.9M | -$105.3M | -$306.6M | -$228.5M | -$45.52M | -$126.2M | -$140.5M |
| Income Tax Expense | $2.9M | $2.7M | -$6.6M | -$18.2M | -$5.1M | -$266K | -$4.2M | -$36.8M |
| Net Income | $28.8M | -$36.1M | -$96.9M | -$276.9M | -$222.5M | -$45.26M | -$122M | -$103.7M |
| Net Income Margin | 3.1% | -4.2% | -12.1% | -38.6% | -33.3% | - | -27.7% | -23.4% |
| Supplementary Data | ||||||||
| EPS | 0.13 | -0.18 | -0.49 | -1.53 | -0.61 | -0.48 | 0.00 | -0.00 |
| Diluted EPS | 0.11 | -0.18 | -0.49 | -1.53 | -0.61 | -0.48 | 0.00 | -0.00 |
| Weighted Average OS | 229.96M | 204.99M | 196.37M | 181.15M | 208.08M | 144.84M | 20.13M | 95.13M |
| EBITDA | $212.9M | $179M | $149M | $104.3M | $43.3M | $68.55M | $98.4M | $72.3M |
| EBITDA Margin | 23.0% | 20.8% | 18.6% | 14.5% | 6.5% | - | 22.4% | 16.3% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $412.3M | $175.2M | $128.8M | $73.5M | $84M | $118.4M | $5K | $5K |
| Short-Term Investments | $6.9M | $5.9M | $5.3M | $4.3M | $4.9M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $419.2M | $181.1M | $134.1M | $77.8M | $88.9M | $118.4M | $5K | $5K |
| Accounts Receivable | $290M | $253.3M | $230.4M | $225.6M | $219.7M | $156.8M | $0 | $0 |
| Inventory | $152.6M | $133.2M | $144.1M | $143.3M | $123.6M | $90.2M | $0 | $0 |
| Other Current Assets | $19.3M | $13.9M | $17.9M | $30.7M | $15.9M | $7.6M | $0 | $0 |
| Total Current Assets | $893.7M | $594.7M | $538.6M | $480.6M | $453.4M | $389.7M | $5K | $5K |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $187M | $176.6M | $167.4M | $164.9M | $169.7M | $75.2M | $0 | $0 |
| Goodwill | $1.87B | $1.43B | $1.45B | $1.42B | $1.66B | $522.6M | $0 | $0 |
| Intangible Assets | $606.3M | $411.6M | $538.8M | $650.4M | $806.9M | $248.3M | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $116.3M | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $28.7M | $26.9M | $26.1M | -$116.3M | $25.4M | $8M | $0 | $0 |
| Total Long-Term Assets | $2.69B | $2.04B | $2.18B | $2.23B | $2.66B | $854.1M | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $24.8M | $0 | $0 | $0 | $0 |
| Total Assets | $3.59B | $2.64B | $2.72B | $2.74B | $3.12B | $1.24B | $5K | $5K |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $57.4M | $56.5M | $58.7M | $67.7M | $59.4M | $38.7M | $636 | $295 |
| Short-Term Debt | $1.6M | $1.2M | $1.2M | $5.3M | $3.9M | $41.1M | $0 | $0 |
| Current Income Tax Payable | $0 | $18M | $4.2M | $14.2M | $10.7M | $0 | $0 | $0 |
| Current Unearned Revenue | $131.8M | $110.9M | $103.4M | $83M | $81.8M | $0 | $0 | $0 |
| Other Current Liabilities | $73.9M | $48.8M | $49.2M | $36.4M | $36.3M | $57.4M | $0 | $0 |
| Total Current Liabilities | $316.1M | $263.5M | $265.7M | $244.3M | $221M | $183.5M | $636 | $295 |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $1.2B | $685.2M | $684.7M | $801.5M | $806.8M | $1.66B | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $3M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $70M | $61.1M | $84M | $116.3M | $161M | $0 | $0 | $0 |
| Other Long-Term Liabilities | $60.7M | $37.1M | $106M | $75M | $104.6M | $119.9M | $0 | $0 |
| Total Long-Term Liabilities | $1.36B | $813.5M | $902.8M | $1.03B | $1.11B | $1.78B | $636 | $295 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | -$636 | -$295 |
| Total Liabilities | $1.67B | $1.08B | $1.17B | $1.27B | $1.33B | $1.96B | $636 | $295 |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $100K | $2K | $2K |
| Retained Earnings | -$512.7M | -$541.5M | -$505.4M | -$408.5M | -$131.6M | -$729.7M | -$636 | -$295 |
| Comprehensive Income & Other | -$52.6M | -$93M | -$65.3M | -$75.7M | -$20.7M | $1.4M | $0 | $0 |
| Other Stockholders' Equity | $2.38B | $2.05B | $1.99B | $1.81B | $1.82B | $10.9M | $3K | $3K |
| Total Equity | $1.87B | $1.51B | $1.48B | $1.4B | $1.69B | -$718.7M | $4K | $5K |
| Minority Interest | $50.5M | $53.5M | $65.5M | $69M | $90.8M | $2.2M | $0 | $0 |
| Total Liabilities and Equity | $3.54B | $2.58B | $2.65B | $2.67B | $3.03B | $1.24B | $5K | $5K |
| Supplementary Data | ||||||||
| Total Debt | $1.23B | $719.9M | $721M | $849.6M | $860.6M | $1.7B | $0 | $0 |
| Net Debt | $821.4M | $544.7M | $592.2M | $776.1M | $776.6M | $1.58B | -$5K | -$5K |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | $28.8M | -$36.6M | -$96.9M | -$288.4M | -$127.9M | -$119.1M | -$341 | -$103.7M |
| Depreciation & Amortization | $138M | $150.4M | $162.8M | $174.5M | $62.9M | $71M | $69.5M | $77M |
| Deferred Income Tax | -$22.3M | -$23.8M | -$30.9M | -$37.2M | -$19.6M | $0 | -$122.1M | $0 |
| Stock-Based Compensation | $15.2M | $15.6M | $21.9M | $31.8M | $0 | $200K | $100K | $200K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $6.2M | -$12M | -$5M | -$19.3M | -$24.3M | $900K | $2.5M | -$11.3M |
| Inventory | $4M | $1.3M | -$500K | -$34.8M | -$5.1M | $2.7M | -$7.9M | -$6M |
| Accounts Payable | -$10.8M | -$1.5M | -$9.9M | $4.5M | $10.3M | $0 | $341 | $0 |
| Other Working Capital | -$15.1M | -$14.6M | $14.7M | $11.2M | $8.1M | -$6.1M | $5.4M | $700K |
| Total Working Capital Change | -$15.7M | -$26.8M | -$700K | -$38.4M | -$11M | -$2.5M | $341 | -$16.6M |
| Other Non-Cash Items | -$700K | $20.3M | $39M | $197.1M | $96.5M | $89.9M | $67.2M | $58.7M |
| Net Cash from Operating | $143.3M | $99.1M | $95.2M | $39.4M | $900K | $39.5M | $14.7M | $15.6M |
| Investing Activities | ||||||||
| Capital Expenditures | -$36.4M | -$48.8M | -$37.1M | -$34.2M | -$17.6M | -$19.9M | -$16.5M | -$12.6M |
| Acquisitions | -$661.9M | -$1M | -$30.4M | -$6.6M | -$2.18B | -$55.7M | -$9.1M | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $3.6M | $0 | $500K | $0 | $0 | $0 | $0 |
| Other Investing Activities | $3.7M | $2.5M | $2.8M | $800K | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$694.6M | -$43.7M | -$64.7M | -$39.5M | -$2.2B | -$75.6M | -$25.6M | -$12.6M |
| Financing Activities | ||||||||
| Debt Repaid | -$422.6M | - | $127.3M | $6.6M | -$804.2M | -$120.4M | -$23.6M | $4.9M |
| Common Stock Issuance | $409.7M | $0 | $150M | $0 | $860.4M | $0 | $0 | $0 |
| Common Stock Repurchases | -$49.6M | -$2M | -$1M | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$6.8M | -$1.3M | $900K | -$400K | -$125.9M | -$1.5M | -$8.6M | -$600K |
| Net Cash from Financing | $775.9M | -$3.3M | $22.6M | -$7M | $1.54B | $118.9M | $15M | -$5.5M |
| Forex Effect | $15M | -$7M | $2.4M | -$3.2M | $746.52M | -$400K | -$2.4M | $400K |
| Net Change in Cash | $239.6M | $45.1M | $55.5M | -$10.3M | $84.22M | $82.4M | $0 | -$2.1M |
| Supplementary Data | ||||||||
| Operating Cash Flow | $143.3M | $99.1M | $95.2M | $39.4M | $900K | $39.5M | $14.7M | $15.6M |
| Capital Expenditure | -$36.4M | -$48.8M | -$37.1M | -$34.2M | -$17.6M | -$19.9M | -$16.5M | -$12.6M |
| Free Cash Flow | $106.9M | $50.3M | $58.1M | $5.2M | -$16.7M | $19.6M | -$1.8M | $3M |
| Cash at Beginning | $175.6M | $130.5M | $75M | $85.3M | $383K | $37.6M | $5K | $38M |
| Cash at End | $415.2M | $175.6M | $130.5M | $75M | $84.6M | $120M | $5K | $35.9M |